Elevated plasma amyloid β-peptide 1–42 and onset of dementia in adults with Down syndrome
- 6 April 2001
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 301 (3), 199-203
- https://doi.org/10.1016/s0304-3940(01)01657-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Plasma amyloid ?-peptide 1-42 and incipient Alzheimer's diseaseAnnals of Neurology, 1999
- The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta 42(43)Neurology, 1997
- Aβ1–40 but not Aβ1–42 levels in cortex correlate with apolipoprotein E ϵ4 allele dosage in sporadic Alzheimer's diseaseBrain Research, 1997
- Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ42(43)Annals of Neurology, 1996
- Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque FormationNeurobiology of Disease, 1996
- Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).Proceedings of the National Academy of Sciences, 1995
- Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down SyndromeAnnals of Neurology, 1995
- Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filamentsNature, 1994
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- The apolipoprotein ε4 allele in patients with Alzheimer's diseaseAnnals of Neurology, 1993